About this trial
The goal of this observational study is to improve the intraoperative diagnosis accuracy of invasiveness for small-sized lung adenocarcinoma by combining multi-modal information. The main question it aims to answer is whether multi-modal information have great value of prediction on the invasiveness for small-sized lung adenocarcinoma. Since a promising limited resection is largely based on intraoperative frozen section diagnosis, there is a growing demand on the high-accuracy of timely pathology diagnosis. The multi-modal information of participants will be collected retrospectively.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
From January 2018 to December 2022, about 3000 patients with lung adenocarcinoma were enrolled in this retrospective study.
Trial design
Cohort
Retrospective
Treatments tested in this trial
Invasiveness diagnosis
Diagnostic testTo predict the invasiveness of patients with small-sized lung adenocarcinoma intraoperatively based on multi-modal information.
Treatment groups
Trial outcomes
Primary outcomes
Final pathology diagnosis of the paraffin section stained with HE
The final pathology diagnosis after resection
Sponsors and contacts
Click on the lead sponsor to view all of their trials.